KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
Leukemia
.
2024 Apr 18.
doi: 10.1038/s41375-024-02244-4.
Online ahead of print.
Authors
Shinju Iyoda
#
1
,
Kenichi Yoshida
#
2
3
,
Kota Shoji
#
1
,
Nana Ito
1
,
Miu Tanaka
1
,
Yasuhito Nannya
2
4
,
Genki Yamato
5
,
Shinichi Tsujimoto
6
,
Norio Shiba
6
,
Yasuhide Hayashi
7
,
Yusuke Shiozawa
8
,
Yuichi Shiraishi
9
,
Kenichi Chiba
9
,
Ai Okada
9
,
Hiroko Tanaka
10
,
Satoru Miyano
10
,
Yuhki Koga
11
,
Hiroaki Goto
12
,
Hiroshi Moritake
13
,
Kiminori Terui
14
,
Etsuro Ito
14
,
Nobutaka Kiyokawa
15
,
Daisuke Tomizawa
16
,
Takashi Taga
17
,
Akio Tawa
18
,
Junko Takita
19
,
Momoko Nishikori
1
,
Souichi Adachi
1
20
,
Seishi Ogawa
2
,
Hidemasa Matsuo
21
22
Affiliations
1
Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
2
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
3
Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan.
4
Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
5
Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan.
6
Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
7
Institute of Physiology and Medicine, Jobu University, Takasaki, Japan.
8
Laboratory of Molecular Analysis, Nippon Medical School, Tokyo, Japan.
9
Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
10
Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
11
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
12
Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
13
Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
14
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
15
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
16
Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
17
Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
18
Department of Pediatrics, Higashiosaka Aramoto Heiwa Clinic, Higashiosaka, Japan.
19
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
20
Shiga General Hospital, Moriyama, Japan.
21
Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan. matsuo@kuhp.kyoto-u.ac.jp.
22
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan. matsuo@kuhp.kyoto-u.ac.jp.
#
Contributed equally.
PMID:
38632314
DOI:
10.1038/s41375-024-02244-4
No abstract available
Grants and funding
JP19K16832/MEXT | Japan Society for the Promotion of Science (JSPS)
JP22K08475/MEXT | Japan Society for the Promotion of Science (JSPS)
JP23K07264/MEXT | Japan Society for the Promotion of Science (JSPS)
Practical Research for Innovative Cancer Control/Japan Agency for Medical Research and Development (AMED)
Project for Development of Innovative Research on Cancer Therapeutics/Japan Agency for Medical Research and Development (AMED)
Project for Cancer Research and Therapeutic Evolution/Japan Agency for Medical Research and Development (AMED)